Treatment-seeking behaviour and stated preferences for prostatectomy in Spanish men with lower urinary tract symptoms

British Journal of Urology

Volumn 79, Issue 5, 1997, Pages 742-748

  Hunter, D J W ^a,b   Berra Unamuno, A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital de la Fuenfria   (Spain)

Author keywords

Lower tract symptoms; Prostatectomy; Treatment seeking behaviour

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; HUMAN; ILLNESS BEHAVIOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; SELF REPORT; SPAIN; SYMPTOM; URETHRA;

EID: 0031402118     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00136.x     Document Type: Article

References (27)

1. Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for Benign Prostatic Hyperplasia in France. J Urol 1994; 151: 1266-70
2. Hunter DJW, McKee CM, Black NA, Sanderson CFB. Urinary symptoms: prevalence and severity in British men aged 55 and over. J Epidemiol Comm Health 1995; 48: 569-75
3. Norman RW, Nickel JC, Fish D, Pickett SN. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships with other symptoms. Br J Urol 1994; 74: 542-50
4. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469-71
5. Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: 85-9
6. Hunter DJW, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men aged 50 and over. J Urol 1996; 155: 1965-70
7. Garraway WM, Russell EB, Lee RJ et al. Impact of previously unrecognized benign prostatic hypertrophy on the daily activities of middle-aged and elderly men. Br J Gen Pract 1993; 43: 318-21
8. Guess HA, Chute CG, Garraway WM et al. Similar levels of urological symptoms have similar impact on Scottish and American men - although Scots report less symptoms. J Urol 1993; 150: 1701-5
9. Sagnier P, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995; 153: 669-73
10. Hunter DJW, McKee CM, Black NA, Sanderson CFB. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 1995; 45: 962-71
11. Hunter DJW, McKee CM, Black NA, Sanderson CFB. The impact of lower urinary tract symptoms on general health status and on the use of prostatectomy. Qual Life Res 1995; 4: 335-41
12. Jacobsen SJ, Girman CJ, Guess HA et al. Do prostate size and urinary flow rates predict health care-seeking behaviour for urinary symptoms in men? Urology 1995; 45: 64-9
13. Simpson RJ, Lee RG, Garraway WM, King D, McIntosh I. Consultation patterns in a community survey of men with benign prostatic hyperplasia. Br J Gen Pract 1995; 44: 499-502
14. Hunter DJW, McKee CM, Black NA, Sanderson CFB. Health care sought and received by men with urinary symptoms, and their views on prostatectomy. Br J Gen Pract 1995; 45: 27-30
15. Holgersen-Bier R, Bruun J. Voiding patterns of men 60 to 70 years old: population survey in an urban population. J Urol 1990; 143: 531-2
16. Mobb GE, Pugh F, Peeling B. How long is your waiting list? Experience of a urological waiting list initiative. J Royal Soc Med 1994; 87: 140-2
17. Barham CP, Pocock RD, James ED. Who needs a prostatectomy? Review of a waiting list. Br J Urol 1993; 72: 314-7
18. Epstein RS, Deverka PA, Chute CG et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 1992; 45: 1431-45
19. Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995; 33: 771-82
20. Vela-Navarette R, Martin-Moreno JM, Calahorra FJ, Damian-Moreno J, Hernandez-Coronado A, Boyle P. Cultural and linguistic validation, in Spanish, of the International Prostatic Symptom Scale. Actas Urol Esp 1994; 18: 841-7
21. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd edn. New York, NY: John Wiley and Sons, 1981
22. SAS Institute Inc. Statistical Analysis System Version 5, 1989
23. Dean AG, Dean JA, Coulombier D et al. EpiInfo, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Center for Disease Control and Prevention. Atlanta, Georgia, USA, 1994
24. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK and the Measurement committee of the AUA. The American Urological Association's symptom index for benign prostatic hyperplasia. J Urol 1992; 158: 1549-75
25. Sommer P, Nielsen KK, Bauer T et al. Voiding patterns in men evaluated by a questionnaire survey. Br J Urol 1990; 65: 155-60
26. Mazur DJ, Hickam DH. Treatment preferences of patients and physicians: Influences of summary data when framing effects are controlled. Med Decis Making 1992; 158: 1549-75
27. McConnell JD, Barry MJ, Bruskewitz RC et al. Benign prostatic hyperplasia: Diagnosis and treatment. Clinical Practice Guideline, Number 8. AHCPR Publication No. 94-0582. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. February 1994